Shorts

Why Pulmonary Fibrosis Diagnosis Takes So Long: Yet Khor, MD, PhD

Focus Turns to Real-World Use, Access as Sparsentan Moves Into FSGS Care: Kirk Campbell, MD

Stop Using 'One Size Fits All' for Pneumonia: Janet Lee, MD

Sparsentan Approval Marks Historic Step Forward for Patients With FSGS: Kirk Campbell, MD

Advocacy Is Not a Solo Endeavor: Rose Gerber, MS

Ensuring Treatment Access Remains Central Challenge in Lung Cancer Care: Deborah Doroshow, MD, PhD

Why Local Cancer Care Is in Crisis: Kathy Oubre, MS

History of Medicine Offers Lessons for Modern Cancer Care: Deborah Doroshow, MD, PhD

AJMC Research Roundup: April 2026

Study Finds Minimal Shifts in Primary Care Selection Following Benefit Design Changes: Tim McDonald, PhD, MPP

Consumer Inertia, Information Gaps Contribute to Inefficiency in Health Care Markets: Bryan E. Dowd, PhD

Efgartigimod Will Likely Be Used as Second-Line Treatment for oMG: Carolina Barnett-Tapia, MD, PhD

BCBSNC Foundation Reflects on 25 Years, Looks Ahead With Renewed Purpose: Katie Eyes, MSW

School Nurses Do Way More Than You Think: Shara Bialo, MD

Why Nurse Navigators are Vital to Oncology Care: Christopher A. D'Avella, MD

BCBSNC Foundation’s Strategy Focuses on Communities, Long-Term Investment, and Root Causes of Health Gaps: Colleen Briggs, MBA

An Inflection Point in Specialty Pharmacy: Fran Gregory, PharmD

The State of Specialty Pharmacy Is Changing Fast

A Medical Misdiagnosis That Led to a Child Protection Case: Joseph Lam, MD

Why Infection Prevention Lags Behind Cancer Research: Muhammad Bilal Abid, MD

Why Pediatric Practices Struggle With Accepting Medicaid: Chris Johnson, MBA

Is the New COVID-19 “Cicada” Variant Dangerous?: Muhammad Bilal Abid, MD

Barriers to Community Oncology Care Referral: Alexa Simon Meara, MD, MS

Why PrEP Options Are Changing Everything: Kelsea Aragon, PharmD

Community Oncology Advocacy Difficult, but Not Impossible: Kathy Oubre, MS

Why Your Prescription Costs Are Outpacing Your Wages: Ulrich Neumann

Why Step Therapy Fails in HIV Prevention: Kelsea Aragon, PharmD

Life-Saving Gene Therapies Cost Up to $4 Million: Fran Gregory, PharmD, MBA

Where Oncology Connects and AI Takes Center Stage: Stephen Schleicher, MD, MBA

Treprostinil Shows Promise as Potential First Inhaled IPF Therapy: Steven D. Nathan, MD